Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kezar Life Sciences (KZR) Debt Ratio (2021 - 2025)

Kezar Life Sciences' Debt Ratio history spans 5 years, with the latest figure at 0.07 for Q1 2025.

  • For Q1 2025, Debt Ratio rose 42.63% year-over-year to 0.07; the TTM value through Mar 2025 reached 0.07, up 42.63%, while the annual FY2024 figure was 0.07, 56.84% up from the prior year.
  • Debt Ratio for Q1 2025 was 0.07 at Kezar Life Sciences, up from 0.07 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.07 in Q1 2025 and bottomed at 0.03 in Q2 2022.
  • The 5-year median for Debt Ratio is 0.04 (2021), against an average of 0.05.
  • The largest annual shift saw Debt Ratio dropped 25.65% in 2022 before it skyrocketed 56.84% in 2024.
  • A 5-year view of Debt Ratio shows it stood at 0.04 in 2021, then decreased by 25.65% to 0.03 in 2022, then skyrocketed by 38.64% to 0.05 in 2023, then surged by 56.84% to 0.07 in 2024, then grew by 1.67% to 0.07 in 2025.
  • Per Business Quant, the three most recent readings for KZR's Debt Ratio are 0.07 (Q1 2025), 0.07 (Q4 2024), and 0.06 (Q3 2024).